ProtoKinetix AAGP® in Phase 3 Retinal Replacement Program

MARIETTA, Ohio--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/AAGP?src=hash" target="_blank"gt;#AAGPlt;/agt;--ProtoKinetix updates its stockholders regarding phase 3 of testing using AAGP® in retinal cell replacement therapy at the UBC